|
|
Volumn 25, Issue 27, 2007, Pages 4326-
|
|
Heat shock protein 70, erythropoietin, and cancer [10]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CASPASE;
ERYTHROPOIETIN;
ERYTHROPOIETIN ANTIBODY;
HEAT SHOCK PROTEIN 70;
PLACEBO;
TRANSCRIPTION FACTOR GATA 1;
ERYTHROPOIETIN RECEPTOR;
RECOMBINANT ERYTHROPOIETIN;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EXPOSURE;
GENE OVEREXPRESSION;
HEAD AND NECK CANCER;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN FUNCTION;
TUMOR CELL;
BIOSYNTHESIS;
CARCINOMA;
DISEASE COURSE;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION;
HEAD AND NECK TUMOR;
METABOLISM;
NOTE;
PHYSIOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
CARCINOMA;
DISEASE PROGRESSION;
ERYTHROPOIETIN, RECOMBINANT;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HEAD AND NECK NEOPLASMS;
HSP70 HEAT-SHOCK PROTEINS;
HUMANS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ERYTHROPOIETIN;
TREATMENT OUTCOME;
|
|
EID: 34948851821
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2007.13.0419 Document Type: Letter |
|
Times cited : (4)
|
|
References (9)
|
